KTN

CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE



Chemical Component Summary

NameCIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE
SynonymsKETOCONAZOLE
Identifiers1-[4-[4-[[(4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
FormulaC26 H28 Cl2 N4 O4
Molecular Weight531.431
TypeNON-POLYMER
Isomeric SMILESCC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H]3COC(O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl
InChIInChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26+/m0/s1
InChIKeyXMAYWYJOQHXEEK-JYFHCDHNSA-N

Chemical Details

Formal Charge0
Atom Count64
Chiral Atom Count2
Bond Count68
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB01026 
NameKetoconazole
Groups
  • approved
  • investigational
DescriptionKetoconazole is an imidazole antifungal agent used in the prevention and treatment of a variety of fungal infections.[FDA Label] It functions by preventing the synthesis of ergosterol, the fungal equivalent of cholesterol, thereby increasing membrane fluidity and preventing growth of the fungus.[A181802,T116] Ketoconazole was first approved in an oral formulation for systemic use by the FDA in 1981.[A188054] At this time it was considered a significant improvement over previous antifungals, [miconazole] and [clotrimazole], due to its broad spectrum and good absorption. However, it was discovered that ketoconazole produces frequent gastrointestinal side effects and dose-related hepatitis.[A188054,A188057] These effects combined with waning efficacy led to its eventual replacement by triazole agents, [fluconazole], [itraconazole], [voriconazole], and [posaconazole]. Ketoconazole and its predecessor [clotrimazole] continue to be used in topical formulations.
Synonyms
  • Ketozole
  • Ketoconazol
  • Ketoconazole
  • Ketoconazolum
Brand Names
  • Ketoderm Cream 2%
  • Nizoral A-D
  • Nizoral Cream 2%
  • Xolegel
  • Ketoconazole 2% / Niacinamide 4%
IndicationKetoconazole is used in the treatment or prevention of fungal infections including blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.[FDA Label] In Europe, it is also used in the treatment of endogenous Cushing's syndrome.[L7736]
Categories
  • 14-alpha Demethylase Inhibitors
  • Agents causing hyperkalemia
  • Anti-Infective Agents
  • Antiadrenal Preparations
  • Anticorticosteroids
ATC-Code
  • G01AF11
  • G01AF20
  • J02AB02
  • H02CA03
  • D01AC08
CAS number65277-42-1

Drug Targets

NameTarget SequencePharmacological ActionActions
Lanosterol 14-alpha demethylaseMSTENTSLVVELLEYVKLGLSYFQALPLAQRVSIMVALPFVYTITWQLLY...unknowninhibitor
Steroid 17-alpha-hydroxylase/17,20 lyaseMWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMH...unknowninhibitor
Androgen receptorMEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPP...unknownbinder
Steroid 21-hydroxylaseMLLLGLLLLPLLAGARLLWNWWKLRSLHLPPLAPGFLHLLQPDLPIYLLG...unknowninhibitor
Potassium voltage-gated channel subfamily H member 2MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCE...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL319160
PubChem 638701
ChEMBL CHEMBL319160
ChEBI CHEBI:47520